Piramal Pharma Limited (PPLPHARMA) — Net Asset Momentum
Piramal Pharma Limited (PPLPHARMA) recorded a net asset momentum of 0.5% as of March 2026, with net assets of Rs81.63 Billion INR. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See operational self-sufficiency of Piramal Pharma Limited to measure how many days the company can operate on defensive assets alone.
YoY Momentum
Current Net Assets
Years of Data
Country
Piramal Pharma Limited Net Asset Momentum (2021–2026)
This chart tracks Piramal Pharma Limited's year-over-year net asset growth across 6 annual reporting periods from 2021 to 2026. The most recent momentum reading is +0.5%, with net assets of Rs81.63 Billion INR as of March 2026. Read PPLPHARMA liabilities breakdown for a breakdown of total debt and financial obligations.
Annual Net Asset History for Piramal Pharma Limited (2021–2026)
The table below shows the complete annual net asset history for Piramal Pharma Limited from 2021 to 2026, covering 6 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see Piramal Pharma Limited stock valuation.
| Year | Net Assets (INR) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2026 | Rs81.63 Billion | Rs179.65 Billion | Rs98.02 Billion | ▲ +0.5% |
| 2025 | Rs81.25 Billion | Rs156.78 Billion | Rs75.52 Billion | ▲ +2.7% |
| 2024 | Rs79.11 Billion | Rs153.12 Billion | Rs74.00 Billion | ▲ +16.8% |
| 2023 | Rs67.73 Billion | Rs145.23 Billion | Rs77.49 Billion | ▲ +1.1% |
| 2022 | Rs66.97 Billion | Rs127.97 Billion | Rs61.00 Billion | ▲ +63.3% |
| 2021 | Rs41.01 Billion | Rs57.57 Billion | Rs16.56 Billion | — |